Does 11β-HSD1 regenerate active cortisol from cortisone?

The conversion of inert glucocorticoid precursors into active hormone represents a critical mechanism for the local, tissue-specific regulation of endocrine signaling. In humans, 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1, encoded by HSD11B1) acts as a key gatekeeper, regulating intracellular glucocorticoid exposure independently of circulating levels.

Mechanistic explanations

• ER luminal microenvironment: Inside intact cells, 11β-HSD1 is anchored to the membrane of the endoplasmic reticulum (ER) with its catalytic site facing the ER lumen.
• Cofactor coupling via H6PD: Its directional activity as a reductase is physiologically sustained by hexose-6-phosphate dehydrogenase (H6PD). H6PD generates local NADPH inside the ER lumen by oxidizing glucose-6-phosphate.
• Reductase dominance: This high local NADPH/NADP⁺ ratio thermodynamically drives 11β-HSD1 to act almost exclusively as a reductase in vivo, converting inactive cortisone into active cortisol.

Clinical implications and physiological roles

• Tissue-specific metabolic control: Local cortisol regeneration is highly active in metabolic tissues such as the liver, skeletal muscle, and both subcutaneous and visceral adipose tissue. In these microenvironments, localized cortisol generation directly drives adipogenesis, lipolysis, and hepatic gluconeogenesis.
• Cortisone reductase deficiency: Genetic mutations in HSD11B1 or H6PD disrupt this intracellular loop. This disruption impairs cortisol regeneration, leading to a compensatory activation of the hypothalamic-pituitary-adrenal (HPA) axis, adrenal androgen excess, and features resembling polycystic ovary syndrome (PCOS).

Bottom line

• Under normal physiological conditions, HSD11B1 functions as a vital reductase driven by H6PD-generated NADPH, regenerating active cortisol from inactive cortisone to locally amplify glucocorticoid receptor signaling across key metabolic and immune tissues.